8-tert-butyl-6,7-dihydropyrrolo(3,2-e)-5-methylpyrazolo(1,5-a)pyrimidine-3-carbonitrile has been researched along with Chronic Disease in 1 studies
*Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funayama, N; Ikegami, K; Imaizumi, M; Ishida, F; Kawatani, M; Nimura, T; Sato, T | 1 |
1 other study(ies) available for 8-tert-butyl-6,7-dihydropyrrolo(3,2-e)-5-methylpyrazolo(1,5-a)pyrimidine-3-carbonitrile and Chronic Disease
| Article | Year |
|---|---|
MK-801 inhibits the micturition reflex in chronic bladder irritation caused by crystalluria in the rat.
Topics: Animals; Chronic Disease; Crystallization; Cystitis, Interstitial; Dizocilpine Maleate; Dose-Response Relationship, Drug; Female; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reflex; Urinary Bladder Diseases; Urination | 2003 |